Study to Evaluate the Safety and Pharmacokinetics of Topically Applied 40% Lidocaine Gel Compared With Placebo in Subjects With Acute Herpes Zoster (Shingles) Pain
Clinical trial NCT02679339 · TERMINATED
Trial details
- NCT number
- NCT02679339
- Sponsor
- Centrexion Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2015-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.